 While pharmaceutical companies often face great risks in the clinical testing arena, they can also suffer extraordinary setbacks in the courtroom, as Bausch Health NYSE: BHC unfortunately demonstrated today. Authorities halted trading on BHC stock as it plunged 50 during the morning session. 